Pay in 4 interest-free payments of $6.94 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Meanwhile, supply security for glucagon-like peptide-1 (GLP-1) agents, stricter reimbursement discussions, and an evolving biosimilar pipeline shape the competitive climate Key Report Takeaways By drug class, oral agents retained 46.95% revenue share in 2025, whereas non-insulin injectables are projected to rise at a 9.74% CAGR through 2031
adults, contributing to more than 60 chronic conditions and costing the U.S
The pituitary responds by releasing more luteinising hormone and follicle-stimulating hormone
Keep the 2-inch distance from the navel
US$ 26.47
US$ 28.87
US$ 20.79
.jpg)
US$ 22.17
US$ 25.19
US$ 24.47
US$ 25.87
